Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 27, 2021Circulation ResearchOpen Access

Nonalcoholic Fatty Liver Disease: An Emerging Driver of Cardiac Arrhythmia

View Full Paper
Ask AI
Bookmark
Share

Why the study?

The upsurge in the prevalence of NAFLD as an emerging risk factor for cardiac arrhythmias has received little attention.

Is nonalcoholic fatty liver disease (NAFLD) an independent risk factor for the development and progression of cardiac arrhythmias?

Design

Review

Authors

ZCZe ChenJLJiayi LiuFZFeng Zhou

Discussion

Loading...

Member takes

Overview

May support arrhythmia risk stratification in NAFLD; leaves open causal confirmation and therapeutic impact.

Structured PICO

Is nonalcoholic fatty liver disease (NAFLD) an independent risk factor for the development and progression of cardiac arrhythmias?

P
Population
Patients with nonalcoholic fatty liver disease (NAFLD)
I
Intervention
Nonalcoholic fatty liver disease (NAFLD) as an exposure/risk factor
O
Outcome
Cardiac arrhythmias (including atrial fibrillation, ventricular arrhythmias, and cardiac conduction defects)

This review highlights NAFLD as an emerging, independent risk factor and potential driver for cardiac arrhythmias, emphasizing the need for increased clinical attention.

Cite This Study

Chen et al. (2021) studied this question.

synapsesocial.com/papers/69f14cccb5f6a2886736ecb3https://doi.org/10.1161/circresaha.121.319059
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort2014 · 94 citations
  2. 2Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases2020 · 173 citations
  3. 3Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity2015 · 475 citations
  4. 42017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary2017 · 410 citations
  5. 5Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD2017 · 708 citations